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Abstract
Firefighters and asphalt pavers are exposed to polycyclic aromatic hydrocarbons (PAHs)
during various work activities. The purpose of this study was to evaluate urinary PAH levels and
compare these bio-monitoring levels among firefighters, asphalt pavers, and non-occupationally
exposed individuals. The National Institute of Standards and Technology (NIST) urinary PAH
levels were used for non-occupationally exposed controls. When compared to the NIST standard
for smokers and non-smokers, firefighters demonstrated statistically significant differences in
urinary concentration differences for the following metabolites: 2-OH-fluorene, 3-OH-fluorene
and 1-OH-pyrene, which were lower in firefighters than the NIST mean for smokers. 1OHphenanthrene, 2-OH-phenanthrene and 3-OH-phenanthrene were higher among world trade
center exposed firefighters than the NIST mean for smokers. When firefighters were compared to
the NIST non-smoker standard, firefighters demonstrated elevated levels in all tested PAH
biomarkers due to a mixture of smokers and non-smokers in the firefighter cohort.
Asphalt workers had statistically significant higher urinary concentration elevations in
2OH-fluorene, 1-OH-phenanthrene and 3-OH-phenanthrene as compared to the NIST smoker
mean. When asphalt pavers were compared to the NIST non-smoker mean, asphalt pavers had
statistically significant increases in all tested PAH biomarkers, with the exception of 2OHphenanthrene. While firefighters did not demonstrate a substantial change in urinary PAH
metabolite levels compared to control populations of smokers and non-smokers, asphalt pavers
experienced concentrations that were in some cases increased by orders of magnitude compare to
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NIST controls. Future research may be needed to evaluate any potential health risk posted to
occupational exposed asphalt pavers.

v

Introduction
Cancer amongst firefighters is an international topic of interest. Politically, the topic is of
great importance since organizations who represent firefighters, including the International
Association of Fire Fighters (IAFF) and the National Fire Protection Association (NFPA),
regularly lobby for legislation to make firefighter cancers presumptively related to occupational
exposure. Awareness that cancer was a potential occupational hazard amongst firefighters
became pervasive during the 1990s. In 1994, a retrospective cohort study was conducted with
5,995 subjects from Toronto area fire departments. It found that firefighters experienced
increased risk of death from cancer of the brain and suggested increased risk for various other
causes of death1. In the 2000s, further studies were performed. In a 2001 mortality study of
Philadelphia firefighters, it was observed that an increased mortality existed for cancers of the
colon and kidney, non-Hodgkin's lymphoma and multiple myeloma2. In 2007, Guidotti evaluated
causality in selected cancer categories for firefighters using the criteria applied in tort litigation
and workers compensation. He reported that an association between firefighters and certain
cancers existed: bladder, kidney, testicular, brain, and lung cancer among non-smokers.
NonHodgkin lymphoma, leukemia and myeloma cancers also merited an assumption of
presumption. His conclusions, however, are not consistent with contemporary epidemiological
firefighter data. In the Nordic study, in which a total of 16,422 male firefighters were included in
the final cohort, a moderate excess risk was seen for all cancer sites combined4. More recently, a
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2015 study that investigated exposure-response relationships for select cancer and non-cancer
health outcomes in a cohort of US firefighters from San Francisco, Chicago and Philadelphia
determined that lung cancer and leukemia mortality risks were modestly increased with
firefighter exposures5. Cancer risk among firefighters is uncertain and available data is
inconsistent. Additional research is required to accurately determine cancer risks.
Firefighters are exposed to an array of compounds, including polycyclic aromatic
hydrocarbons (PAHs)6. Firefighters are not only exposed to PAHs during fire suppression
operations, but also when conducting overhaul of turnout gear and by living in contaminated fire
houses6.
PAHs are a class of organic compounds produced by incomplete combustion or
highpressure processes7. PAHs often consist of three or more fused benzene rings composed of
only carbon and hydrogen. There are 18 PAHs that are commonly produced during fires8. Of
these, the World Health Organization’s International Agency for Research on Cancer (IARC)
classifies one as being carcinogenic to humans (benzo[a]pyrene) and eight others as being
possibly or probably carcinogenic to humans9. Smoke contains particulate and gaseous phases,
both of which contain PAHs6.
When actively suppressing fires, firefighters typically wear protective ensembles that are
compliant with NFPA standards and a Self Contained Breathing Apparatus (SCBA). Even when
properly utilizing the aforementioned protective equipment, it has been demonstrated that
firefighters absorb PAHs during fire suppression activities8. Asphalt, also known as bitumen, is
primarily utilized in the United States for road paving and exposure is known to potentially cause
DNA damage18. It contains a mixture of polycyclic aromatic compounds which leads asphalt
pavers to be exposed to PAHs. PAH metabolites are accepted biomarkers for monitoring
2

exposure to asphalt emissions16,20 and urinary 1-OH-Pyrene has proven to be a favorable
predictor of oxidative DNA damage, specifically in asphalt exposed workers17. Urinary PAHs in
asphalt pavers is associated with both inhalation and dermal exposure19, with dermal exposure
being the primary route11,15. Scientific evidence exists to suggest that asphalt pavers have an
excess risk of cancer, although it is not clear if the increased cancer risk is secondary to only
asphalt exposure or a combination of asphalt, diesel oil, tobacco and tar exposure11. In 2015,
Rhomberg et al. performed a robust investigation to examine quantitative risks for roofing
workers exposed to asphalt. It was reported that epidemiology studies do not consistently report
elevated risks, nor do they have sufficient exposure evidence or satisfactory control for
confounders. As such, much of the existing data was deemed inadequate for dose–response
analysis. When Environmental Protection Agency consistent time-to-tumor model methods were
applied to quantify potential cancer risks, roofers (with both dermal and inhalation exposure to
asphalt) had cancer risks within a range typically considered acceptable within regulatory
frameworks21. As of 2014 there were approximately 58,000 asphalt pavers in the United States.
Job growth is expected to be faster than average22.

Objective:

The purpose of this study was to evaluate urinary PAH metabolite levels and

compare these bio-monitoring levels among firefighters, asphalt pavers and non-occupationally
exposed controls.
Hypothesis: A hypothesis that firefighters would have elevated urinary PAH metabolite levels
when compared to the NIST standards was adopted.
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Research Questions:
1. Do firefighters have elevated urinary PAH metabolite levels as compared to the general
smoking and non-smoking population (NIST standards)?
2. How do urinary PAH metabolite levels compare between firefighters and asphalt pavers?

4

Methods
In 2014, the National Institute of Standards and Technology (NIST) developed two new
Standard Reference Materials (SRMs), SRM 3672 Organic Contaminants in Smokers’ Urine
(frozen) and SRM 3673 Organic Contaminants in Non-Smokers’ Urine (frozen), which included
polycyclic aromatic hydrocarbons (PAHs). This standard was derived by combining data from:
NIST, the Centers for Disease Control and Prevention (CDC), and the Institut National de Santé
Publique du Québec (INSPQ)13.
In 2003, the CDC published a case control study which compared blood and urine
specimens of firefighters who responded to the World Trade Center (WTC) disaster to
firefighters who were not present at the WTC. Sampling occurred 3 weeks after September 11,
2001. A total of 110 potentially fire related chemicals were analyzed, including urinary PAH
metabolites. The study had 318 WTC disaster exposed firefighters and 47 firefighter controls
who were not at the WTC. Urinary PAH data was ultimately collected for four cohorts: control
firefighters, firefighters who were present at the WTC collapse, firefighters who were present on
WTC post-collapse days 1 and 2 but were not present at collapse, and special operations
command firefighters10.
In 2012, a study using urinary biomarkers of PAHs to guide exposure-reduction strategies
among asphalt pavers was conducted. 480 urine samples were collected from 12 paving workers
over 3 workdays during 4 workweeks. Preshift, postshift, and bedtime urine samples were
collected and analyzed for 1-OH-pyrene; 1-, 2-, 3-, 4-OH-phenanthrene; 1-, 2-OH-naphthalene;
and 2-, 3-, 9-OH-fluorene. Each of the 4 weeks represented a different exposure scenario: a
5

baseline week (normal conditions), a dermal protection week (protective clothing), a powered
air-purifying respirator (PAPR) week, and a biodiesel substitution week (100% biodiesel
provided to replace the diesel oil normally used by workers to clean tools and equipment)11.
Using the cumulative results from each exposure scenario, the average of each urinary
PAH was calculated and used for comparative analysis with the CDC firefighter data (not
including special operations command firefighters) and the NIST standards. A hypothesis that
firefighters would have the same urinary PAH metabolite levels when compared to the NIST
standards was adopted. Microsoft Excel was used to perform calculations and T-test was utilized
for statistical analysis.
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Results
When compared to the NIST standard for smokers and non-smokers, firefighters
demonstrated statistically significant differences in urinary concentrations for the following
metabolites: 2-OH-fluorene, 3-OH-fluorene and 1-OH-pyrene, which were lower in firefighters
than the NIST mean for smokers. 1-OH-phenanthrene, 2-OH-phenanthrene and 3OHphenanthrene were higher among world trade center exposed firefighters than the NIST mean
for smokers. When firefighters were compared to the NIST non-smoker standard, firefighters
demonstrated elevated levels in all tested PAH biomarkers due to a mixture of smokers and
nonsmokers in the firefighter cohort. Asphalt workers had statistically significant higher urinary
concentrations of 2-OH-fluorene, 1-OH-phenanthrene and 3-OH-phenanthrene as compared to
the NIST smoker mean. The results of statistical analyses between firefighter and asphalt paver
cohorts is summarized in tables 7-12.
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Tables
Table 1. Results Summary of 2-OH-fluorene comparisons among cohorts and NIST standards
Smoker standard (0.854 ng/g)
2-OH-Fluorene
Contol firefighters
Firefighters A*
Firefighters B**
Asphalt Pavers

Mean (ng/mL) P value

Interpretation

Non-smoker standard (0.105 ng/g)
P value

Interpretation

0.586754

3.2301E-83 Statistically lower

3.20544E-94 Statistically higher

0.631218

6.637E-235 Statistically lower

1.1586E-285 Statistically higher

1.911E-263 Statistically lower

0 Statistically higher

0.6825
1.49

6.7834E-06 Statistically higher

1.62747E-19 Statistically higher

Table 2. Results Summary of 3-OH-fluorene comparisons among cohorts and NIST standards
Smoker standard (0.42 ng/g)
3-OH-Fluorene
Contol firefighters
Firefighters A*
Firefighters
B**
Asphalt Pavers

Mean (ng/mL) P value

Interpretation

Non-smoker standard (0.0384 ng/g)
P value

Interpretation

0.253128 1.7326E-70

Statistically lower

3.40544E-75 Statistically higher

0.216393 2.529E-84

Statistically lower

8.19069E-82 Statistically higher

Statistically lower

1.21907E-87 Statistically higher

0.242954
0.56

6.0642E-85

0.31733679 Not significant

0.021716297 Statistically higher

Table 3. Results Summary of 1-OH-phenanthrene comparisons among cohorts and NIST
standards
Smoker standard (0.133 ng/g)
1-OH-Phenanthrene Mean (ng/mL) P value
Contol firefighters
Firefighters A*
Firefighters B**
Asphalt Pavers

Interpretation

Non-smoker standard (0.0479 ng/g)
P value

Interpretation

0.164906 9.9757E-49

Statistically higher 6.10192E-73 Statistically higher

0.181871 3.7246E-64
0.202025 1.3095E-69

Statistically higher 5.60143E-83 Statistically higher

0.42

0.0504374

Statistically higher

1.3204E-84 Statistically higher

Statistically higher 0.013760436 Statistically higher
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Table 4. Results Summary of 2-OH-phenanthrene comparisons among cohorts and NIST
standards
Smoker standard (0.0825 ng/g)
2-OH-Phenanthrene Mean (ng/mL) P value
Contol firefighters
Firefighters A*
Firefighters B**
Asphalt Pavers

Interpretation

Non-smoker standard (0.0242 ng/g)
P value

Interpretation

0.130505 3.6835E-56

Statistically higher 5.49903E-71 Statistically higher

0.154251 5.5597E-71
2.1432E-77
0.187573
0.20360431
0.23

Statistically higher 4.38962E-82 Statistically higher
Statistically higher 1.23024E-85 Statistically higher
Not significant

0.110332894 Not significant

Table 5. Results Summary of 3-OH-phenanthrene comparisons among cohorts and NIST
standards
Smoker standard (0.123 ng/g)
3-OH-Phenanthrene Mean (ng/mL) P value
Contol firefighters
Firefighters A*
Firefighters B**
Asphalt Pavers

Interpretation

Non-smoker standard (0.0271 ng/g)
P value

Interpretation

0.133099 1.2112E-30

Statistically higher

3.8004E-74 Statistically higher

0.155891 1.2478E-59
2.7345E-69
0.177834
0.02459616
0.45

Statistically higher 4.18788E-85 Statistically higher
Statistically higher 3.61752E-88 Statistically higher
Statistically higher 0.004555996 Statistically higher

Table 6. Results Summary of 1-OH-pyrene comparisons among cohorts and NIST
Smoker standard (0.17ng/g)
1-OH-Pyrene
Contol firefighters
Firefighters A*
Firefighters B**
Asphalt Pavers

Mean (ng/mL) P value

Interpretation

0.062417 1.3867E-69

Non-smoker standard (0.0299 ng/g)
P value

Interpretation

Statistically lower

2.66448E-47 Statistically higher

0.092129 2.3245E-69 Statistically lower
2.5817E-65 Statistically lower
0.106306
0.06403632 Not significant
0.55

3.55019E-65 Statistically higher
1.03898E-68 Statistically higher
0.014650798 Statistically higher

Table 7. Results Summary of 2-OH-fluorene comparisons between firefighters and asphalt
pavers cohorts
2-OH-Fluorene
Control firefighters vs. Asphalt Pavers

P value
1.56E-106

Firefighters A* vs. Asphalt Pavers

0

Firefighters B** vs. Asphalt Pavers

0

Ctrl.Firef vs. Firefighters A*

3.9318E-299

Ctrl.Firef vs. Firefighters B**
Firefighters A* vs. Firefighters B**

0
2.3894E-06
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Table 8. Results Summary of 3-OH-fluorene comparisons between firefighters and asphalt
pavers cohorts
3-OH-Fluorene
Control firefighters vs. Asphalt Pavers

P value
1.08951E-14

Firefighters A* vs. Asphalt Pavers

0

Firefighters B** vs. Asphalt Pavers

0

Ctrl.Firef vs. Firefighters A*

7.058E-247

Ctrl.Firef vs. Firefighters B**

6.5582E-192

Firefighters A* vs. Firefighters B**

0.118476817

Table 9. Results Summary of 1-OH-phenanthrene comparisons between firefighters and asphalt
pavers cohorts
1-OH-Phenanthrene
Control firefighters vs. Asphalt Pavers

P value
1.04151E-24

Firefighters A* vs. Asphalt Pavers

0

Firefighters B** vs. Asphalt Pavers

0

Ctrl.Firef vs. Firefighters A*

4.4437E-239

Ctrl.Firef vs. Firefighters B**
Firefighters A* vs. Firefighters B**

0
0.08809833

Table 10. Results Summary of 2-OH-phenanthrene comparisons between firefighters and asphalt
pavers cohorts
2-OH-Phenanthrene
Control firefighters vs. Asphalt Pavers

P value
2.02227E-06

Firefighters A* vs. Asphalt Pavers

0

Firefighters B** vs. Asphalt Pavers

0

Ctrl.Firef vs. Firefighters A*

2.4757E-274

Ctrl.Firef vs. Firefighters B**
Firefighters A* vs. Firefighters B**

0
0.001757247
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Table 11. Results Summary of 3-OH-phenanthrene comparisons between firefighters and asphalt
pavers cohorts
3-OH-Phenanthrene
Control firefighters vs. Asphalt Pavers

P value
6.3959E-35

Firefighters A* vs. Asphalt Pavers

0

Firefighters B** vs. Asphalt Pavers

0

Ctrl.Firef vs. Firefighters A*

1.9564E-284

Ctrl.Firef vs. Firefighters B**
Firefighters A* vs. Firefighters B**

0
0.047169349

Table 12. Results Summary of 1-OH-pyrene comparisons between firefighters and asphalt
pavers cohorts
1-OH-Pyrene
Control firefighters vs. Asphalt Pavers

P value
1.23012E-39

Firefighters A* vs. Asphalt Pavers

0

Firefighters B** vs. Asphalt Pavers

0

Ctrl.Firef vs. Firefighters A*

2.1247E-301

Ctrl.Firef vs. Firefighters B**
Firefighters A* vs. Firefighters B**

0
0.258521634
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Figures

Figure 1. Histogram depicting mean urine concentrations of 2-OH-Fluorene among cohorts and
NIST standards.
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Figure 2. Histogram depicting mean urine concentrations of 3-OH-Fluorene among cohorts and
NIST standards.
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Figure 3. Histogram depicting mean urine concentrations of 1-OH-Phenanthrene among cohorts
and NIST standards.
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Figure 4. Histogram depicting mean urine concentrations of 2-OH-Phenanthrene among cohorts
and NIST standards.
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Figure 5. Histogram depicting mean urine concentrations of 3-OH-Phenanthrene among cohorts
and NIST standards
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Figure 6. Histogram depicting mean urine concentrations of 1-OH-Pyrene among cohorts and
NIST standards.
* Firefighters A represent those present at the WTC collapse.
**Firefighters B represent those who were present on WTC post-collapse days 1 and 2 but were
not present at collapse
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Discussion
Presumptive disability laws link a specific occupation with a disease or condition that has
been shown to be a hazard associated with that occupation. By establishing an association, if an
individual employed in the occupation covered by the presumption develops a disease or
condition that is specified in the presumptive law, then that disease or condition is presumed to
have come from that occupation. As such, the burden of proof shifts from the employee to the
employer to establish that the condition was not in fact associated with the occupation but with
an alternative cause.
Prior to 2002, no firefighter in the world was automatically covered for medical expenses
related to presumed occupationally induced cancer. Now 90% of firefighters in Canada and
Australia have some coverage along with firefighters in 33 US states12. As lawmakers
continually debate whether or not to implement more presumptive legislation, a benefit that
would cost an immense amount of tax payer funds, it is important to take into account the
strength of all available scientific evidence as it relates to causality. Hill’s criteria should be
applied. There are ethical considerations both in caring for public servants who risk their lives in
performing their occupational duties and in sensibly spending tax monies that continually
become scarcer due to political and societal demands.
A potential for skewed urinary PAH levels secondary to the sample cohorts having a
mixture of smokers and non-smokers exists. The firefighter cohort was composed of a mixture of
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both smokers and non-smokers. Using a serum cotinine greater than to 10 ng/mL to determine
smoker status, 87 of the 358 (24.3%) firefighters with measured serum cotinine in the analysis
groups were smokers. In the asphalt paver cohort, five of the workers were nonsmokers, six
smoked cigarettes, and one was a smoker who quit during the study. One of the nonsmokers
chewed tobacco14.
When considering data to include in this investigation, a comprehensive literature search
was performed. After using inclusion criteria of having: 1) specific occupational groups
identified and 2) urinary PAH data that matched available NIST standards, data sets from the
WTC firefighter study and the asphalt paver exposure-reduction study were ultimately used for
comparative analysis. Available data sets that did not characterize sub-populations were
excluded. The WTC firefighter study had notable strengths and weaknesses. The main strength
of the firefighter study is that it is the most robust biomonitoring study ever done on any
occupational cohort during the initial weeks of exposure to a major fire, building collapse or
urban disaster10. Other key advantages of the study are the sheer number of compounds tested
(110) and number of participant firefighters (318 exposed and 47 controls). The collaborative
effort between CDC-NIOSH and the New York City Fire Department Bureau of Health Services
ensured that data collection and medical monitoring were performed appropriately.
Biomonitoring protocol to quantify chemicals in firefighter blood and urine was developed by
the CDC’s National Center for Environmental Health, Division of Laboratory Sciences, which
further added to the validity of the study. It should be noted that the reason special operations
firefighters were not included in this study is because raw data was not available from this
cohort.

Biomonitoring data is ideal when collected in conjunction with measurements of

external exposure. Since it is not feasible to perform personal sampling of external exposures
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during times of disaster, it would be unreasonable to consider this missing element a weakness
of the study, although it should be discussed. The most obvious limitation of this study is that the
biomonitoring measurements were made at only one point in time. If data could have been
serially collected from the initial fire onward, that would have been advantageous for
investigating chemicals with short half-lives.
Other issues to consider are the control group and exposures to substances not tested. The
control group consisted of New York firefighters who had been placed on office duty, which
may have limited their exposure to any recent fires. Substances such as asbestos, fiberglass,
silicates and other inorganic particles are not subject to biomonitoring, so the study cannot
provide insight into the potential effects of exposure.
In the asphalt paver exposure-reduction study, there were 480 asphalt paver urine
samples which originated from only 12 workers. Since the urine samples were collected at
different times of the day and after various methods of exposure mitigation, we used average
urinary PAH concentrations in our analysis as it was not deemed necessary to perform separate
analysis on each category of available asphalt paver urine. However, since three of the four study
weeks featured samples from varying methods of exposure protection (not typically used in
current dayto-day practice), there is potential for the urine PAH results to be skewed to lower
concentrations. Although our analysis demonstrated various statistically significant elevations in
urinary
PAH concentrations in both firefighters and asphalt pavers as compared to the general population
(NIST standards), we cannot conclude that an increased risk of cancer for firefighters and asphalt
pavers exists. Cancer is generally the result of chronic exposure and the data used in this study
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could be from acute or sub-chronic exposure. Furthermore, quantifiable urinary PAH levels that
cause cancer do not exist.
Asphalt workers (and other occupations who do not currently have medical coverage
through presumptive legislation, i.e. coke oven workers and diesel mechanics) do not possess the
level of political influence that firefighters have. The results of this study makes evident that
future research may be necessary to evaluate potential health risk for occupationally exposed
asphalt pavers. Eventually, presumptive legislation laws for non-firefighter professions with
elevated PAH contact could be deliberated.
The authors of this paper do not imply that risk is associated with PAH exposure. Our
findings relate only to exposure levels. Furthermore, we do not imply that any statistically
increased PAH metabolite levels equate to increased risk or clinical importance.
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Conclusions
While firefighters did not demonstrate a substantial change in urinary PAH metabolite
levels compared to control populations of smokers and non-smokers, asphalt pavers experienced
concentrations that were in some cases increased by orders of magnitude compared to NIST
controls. Future research may be needed to evaluate any potential health risk for occupationally
exposed asphalt pavers.
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